Next stop, Milan - Welcome to Italy's life sciences hub
Milan is home to an internationally competitive pharmaceutical, biotechnology and functional foods hub, with strong growth prospects and a commitment to innovation across its entire supply chain. Italy is also home to one of the most advanced and efficient healthcare systems in Europe - making it an exciting destination for the 2021 CPHI Worldwide event.
CPHI Worldwide is back
From 9-11 November 2021, CPHI Worldwide will take place in Milan, Italy, after a two-year, COVID-19 induced break.
This year, the event is going hybrid, with an online platform open four weeks prior to the in-person event for matchmaking, networking and meetings. There is also a online content programme of 50+ sessions being broadcast from 25 October onwards - giving attendees all the insights they need to prepare for both virtual and on-site meetings in Milan.
The world's largest pharmaceutical gathering was last held in Lombardy's capital in 2007, so this year marks a long-awaited return not only to the in-person experience of CPHI Worldwide, but also to the epicentre of the Italian pharmaceutical industry.
What makes Milan such an exciting destination for pharma?
.png)
Learn more about Milan's ecosystem for life sciences
Did you know that the Greater Milano Region generates 33% of the Italian registered patents in the EU and supplies 5% of the world's active ingredients? Local Life Sciences production is worth €71 billion and employs 356,000 people.
For more information, take a look at Yes Milano's comprehensive report on Milan's life sciences ecosystem, including the innovation district, research excellence, talent development and manufacturing expertise.
You can also hear directly from Milano&Partners at the CPHI Worldwide online content programme, join us on 25 October to explore macro data and regional successes. If you have not yet registered for the CPHI Worldwide hybrid event, there is still time, whether you;re joining us in-person or online.
Register for CPHI Worldwide now
Planning to join us in Milan?
If you'll be visiting CPHI Worldwide in Milan this year, there are several useful resources on the CPHI Worldwide website covering visa applications, COVID-19 measures, accommodation and the Informa AllSecure commitments for a safe and enjoyable event experience.
Prepare for your trip to Milan
Ci vediamo lì!
Related News
-
News A Day in the Life of a Vice President of Business Development
In this month's Day in the Life Of interview, I spoke to Nigel Stapleton, VP of Business Development in Biopharmaceutical Contract Manufacturing for Mabion SA, about his illustrious career and some personal highlights. -
News Pharmaceutical Packaging Market Prospects: Shifting regional policies
The pharmaceutical packaging industry is experiencing significant transformation in 2025, driven by regulatory changes, supply chain challenges, and sustainability initiatives. The US BIOSECURE Act, passed through the House of Representatives in Septem... -
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News China import tax fine could cost AstraZeneca up to US$8 million
British-Swedish drugmaker AstraZeneca could find itself facing fines of up to US$8million in China due to suspected unpaid import taxes on breast cancer drug Enhertu.
-
News Women in Pharma: Building from the ground up together
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pharmaceutical Packaging Market Prospects – Innovations in Packaging and Drug Delivery
Download the Pharmaceutical Packaging Market Prospects Trend Report to explore the full report and delve into the evolving opportunities in pharmaceutical packaging and drug delivery. -
News Novartis to invest US$23 billion in US facilities amid tariff threats
Swiss pharmaceutical giant Novartis has announced its intention to invest up to US$23 billion in building and expanding ten pharmaceutical facilities in the US as drugmakers scramble to respond to potential drug import and manufacturing tariffs declare... -
News CPHI Podcast Series: Fulfilling an unmet need for rare disease patients
Our April episode from the CPHI Podcast Series is looking into rare diseases, and more specifically how pharmaceutical companies can better support this smaller population of rare disease patients.